Severe acute respiratory syndrome (SARS): a year in review.
about
Global transport networks and infectious disease spreadCross-Species Virus Transmission and the Emergence of New Epidemic DiseasesStructural Basis for the Identification of the N-Terminal Domain of Coronavirus Nucleocapsid Protein as an Antiviral TargetInfluenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tractsVaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variantsThe papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzymeCoordinated response to SARS, Vancouver, Canada.Management of natural and bioterrorism induced pandemics.Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America.Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.The University of Washington Health Sciences Library BioCommons: an evolving Northwest biomedical research information support infrastructure.Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.Insights into the evolution and emergence of a novel infectious diseaseA conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccineThe spike protein of SARS-CoV--a target for vaccine and therapeutic development.Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses.Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screeningsApplications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.The great opportunity: Evolutionary applications to medicine and public healthRemaining questions about clinical variola major.SARS-CoV regulates immune function-related gene expression in human monocytic cells.Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?Virus pathogen database and analysis resource (ViPR): a comprehensive bioinformatics database and analysis resource for the coronavirus research community.Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.SARS vaccines: where are we?Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein.Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infectionPolitical will and international collaborative frameworks in infectious diseases.Epidemic spreading in networks with nonrandom long-range interactions.Determining SARS sub-clinical infection: a longitudinal seroepidemiological study in recovered SARS patients and controls after an outbreak in a general hospital.Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptide valinomycin in Streptomyces tsusimaensis ATCC 15141.Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome.Sliding mode control of outbreaks of emerging infectious diseases.What is the best control strategy for multiple infectious disease outbreaks?Echinacea—A Source of Potent Antivirals for Respiratory Virus Infections.
P2860
Q24576083-0D96DB94-9ADB-4C50-9369-9103FB4B4D1DQ27486915-D8052E76-7777-4B27-B214-E26F80221D47Q27681874-255ED5A2-9950-4764-A5C0-8CA2DB1DED0AQ28730201-7D4C2EA0-B088-445D-9202-AD5C88C954E4Q28764574-1C586EB7-1301-48CE-8CC9-17C0122A516AQ28768791-9B9BF91D-9191-43F3-9209-F121EB127348Q30231281-301A71ED-9B56-4D62-A652-83F7A9E14497Q30364483-0897ECFE-0018-4738-A4B4-1194D91C4B84Q30380066-FE61DEFB-6BF3-4CBD-9A7C-552FBCABDC29Q30951751-97376D67-F50C-4DE8-A851-0A270F4D21DEQ33252839-E9B424D6-7DA4-48C5-92C8-35AB26E9AE67Q33558501-DE9DAF25-FD12-4F89-8DC4-A03D531DC26DQ33717028-975F2972-C89F-448A-9DAF-11CD1B2A93B7Q33743790-E3A46E41-1BF8-4B2E-858A-0EC3E5ABE171Q33863306-2E172C90-673B-4B9F-A076-067B771D0FFCQ34015988-09AB298A-C501-44F0-AF9C-78F863DFCA7EQ34324907-5407A896-0B0D-41A3-B794-38F617EB7B71Q34504137-FEBCAF34-1FF9-4147-B17C-828A4FB0BE2DQ35065902-225E7ADA-B5DA-4065-82B6-D6F7CAB9B3DDQ35494999-D41B7C10-1EA8-45E7-97EB-19B43DF3D4B0Q35960713-C72B6E31-A866-46FE-B5D7-1C9E63575435Q36039631-E52B5D68-B74E-4A9A-969D-C2E61ACE71FAQ36144565-817C89A3-55BC-4C49-A07E-1E6F0CC7F9ACQ36404194-77B00BEA-ACB8-405B-BF29-79F6B3AC5EBFQ36432773-B789F768-3FA6-4CC8-A0C4-F66E4C228D47Q37366744-EB8F2C84-82FB-4E40-9EED-4BBDF5801D0EQ37524036-1A527118-9B3E-47A5-9727-1F0F3B2AFECEQ39239315-0FDB6923-E0B8-4629-87DA-38C79DD7E568Q39677274-A23FC7D2-B658-411B-850F-2B95C5BE7831Q41546580-919F75FC-1E18-429F-83A4-D7C216F0FB1FQ44595041-3F824ACE-22F1-46AA-AD24-C6A25663BC50Q44712358-EF495676-E447-4786-BD95-5AD857F8C0AEQ46971666-1218B0AC-BA49-4DF5-83AF-92B35254326FQ47721502-30934F44-2250-4808-8DA4-9434CCF9A60AQ51339766-5294481B-82BC-4FA4-B6C2-B2BE6923A74BQ55113923-596C83C8-5509-4C56-8493-EA7E8C799205Q55617078-7AC3D301-12A7-400A-AC99-6320EBA6A876
P2860
Severe acute respiratory syndrome (SARS): a year in review.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Severe acute respiratory syndrome (SARS): a year in review.
@ast
Severe acute respiratory syndrome (SARS): a year in review.
@en
type
label
Severe acute respiratory syndrome (SARS): a year in review.
@ast
Severe acute respiratory syndrome (SARS): a year in review.
@en
prefLabel
Severe acute respiratory syndrome (SARS): a year in review.
@ast
Severe acute respiratory syndrome (SARS): a year in review.
@en
P2093
P1476
Severe acute respiratory syndrome (SARS): a year in review.
@en
P2093
Caroline Astell
Danuta M Skowronski
Lorne Babiuk
Martin Petric
Pierre J Talbot
Robert C Brunham
Theresa Tam
P304
P356
10.1146/ANNUREV.MED.56.091103.134135
P577
2005-01-01T00:00:00Z